Donation - Treatment options

The programme "Our chance - In vitro with donor cells"

The aim of the programme is to provide comprehensive care to couples who will use egg cells from the TFP Fertility Macierzyństwo bank during the in vitro procedure.

The eggs in the TFP Fertility Macierzyństwo bank come from women who have decided to anonymously donate some oocytes during their own IVF treatment. A potential donor must be under 35 years of age, have no health contraindications to donation other than partner donation, and donate at least 4 mature eggs. Donors undergo a full package of virological tests and additional genetic tests (CFTR).

The programme covers the full cycle of treatment - from the start of the cycle until the last embryo is used.

The programme consists of:

• Gynaecological consultations with ultrasound

• Monitoring of hormone levels (oestradiol, progesterone, HCG) from the beginning of the cycle until the end of the programme (confirmed clinical pregnancy or use of the last embryo)

• Psychological care during the whole process

• Virological examinations for HIV, HCV, HBs (by amplification of nucleic acids)

• Selection of oocytes according to phenotypic characteristics, thawing and use of oocytes from the clinic's bank in accordance with the requirements of the Act of 25 June 2015 on infertility treatment (Journal of Laws of 31 July 2015, item 1087) and the Regulations of the Minister of Health issued to the aforementioned Act

• IVF/ICSI in vitro fertilisation

• Embryo culture

• Freezing and storage of embryos for the first year from the date of freezing

• Embryo transfers of fresh and frozen embryos

• Verification of HCG levels after embryo transfers

What have we not included in the programme?

• Examinations and consultations necessary for the qualification for the in vitro procedure

• Medication to prepare for the embryo transfer, luteal phase supplementation

• Additional techniques in the IVF procedure, which may in some situations increase the efficiency of the procedure, but are not essential:

• IMSI

• Assisted Hatching (AH)

• EmbryoScope

• EmbryoGlue

• Costs of storing embryos beyond the first year

Use of donor semen

TFP Fertility Macierzyństwo works with the European Sperm Bank. The European Sperm Bank donor material is available on-site at our clinic's bank, enabling the selection of a donor with the required phenotypic characteristics (appearance). Once the donor phenotypic selection is approved by the attending physician, the donor material is reserved at no cost for the couple's treatment needs and then used for the insemination or in vitro fertilization procedure.

In situations where the phenotypic characteristics of donors from the TFP Fertility Macierzyństwo bank do not match the couple undergoing treatment, it is possible to select and import donor sperm directly from the European Sperm Bank europeanspermbank.com.

Embryo adoption

The aim of the programme is to provide comprehensive care to couples who have decided to adopt embryos.

Embryos are donated for adoption by couples who have successfully completed treatment and are not planning any more children, or have otherwise decided to donate embryos.

The embryo adoption programme consists of:

• Gynaecological consultations with ultrasound

• Monitoring of hormone levels (oestradiol, progesterone, HCG) from the beginning of the cycle until the end of the programme (embryo transfer)

• Psychological care during the whole process

• Virological examinations of HIV, HCV, HBs (by amplification of nucleic acids)

• Phenotypic selection, thawing and use of embryos donated for adoption from the TFP Fertility Macierzyństwo bank in accordance with the requirements of the Act of 25 June 2015 on the treatment of infertility (Journal of Laws of 31 July 2015, item 1087) and the Regulations of the Minister of Health issued to the aforementioned Act

• Assisted Hatching (AH)

• Embryo/embryo transfer

• Verification of HCG levels after embryo transfer

What have we not included in the programme?

• Examinations and consultations necessary for qualification for the procedure

• Medication to prepare for the embryo transfer, luteal phase supplementation.